相似文献
1
Pneumococcal surface protein A of invasive Streptococcus pneumoniae isolates from Colombian children.
Emerg Infect Dis. 2001 Sep-Oct;7(5):832-6. doi: 10.3201/eid0705.017510.
2
Typing of pneumococcal surface protein A (PspA) in Streptococcus pneumoniae isolated during epidemiological surveillance in Brazil: towards novel pneumococcal protein vaccines.
Vaccine. 2004 Sep 28;22(29-30):3890-6. doi: 10.1016/j.vaccine.2004.04.009.
3
Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
Immunol Invest. 2015;44(5):482-96. doi: 10.3109/08820139.2015.1037956.
4
Enhanced protective immunity against pneumococcal infection with PspA DNA and protein.
Vaccine. 2006 Jul 17;24(29-30):5755-61. doi: 10.1016/j.vaccine.2006.04.046. Epub 2006 May 4.
5
Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.
Infect Immun. 2005 Mar;73(3):1304-12. doi: 10.1128/IAI.73.3.1304-1312.2005.
6
Antibodies to the pneumococcal surface protein A, PspA, can be produced in splenectomized and can protect splenectomized mice from infection with Streptococcus pneumoniae.
Vaccine. 2005 Jul 21;23(33):4257-62. doi: 10.1016/j.vaccine.2005.03.039.
7
Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
Vaccine. 2011 Aug 5;29(34):5731-9. doi: 10.1016/j.vaccine.2011.05.095. Epub 2011 Jun 13.
8
Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection.
J Infect Dis. 2007 Jan 15;195(2):185-93. doi: 10.1086/509807. Epub 2006 Dec 4.
9
Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA.
J Infect Dis. 2000 Dec;182(6):1694-701. doi: 10.1086/317602. Epub 2000 Nov 8.
10
Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
Microb Pathog. 2009 Sep;47(3):151-6. doi: 10.1016/j.micpath.2009.05.004. Epub 2009 May 23.
引用本文的文献
1
Preliminary Evaluation of the Safety and Immunogenicity of a Novel Protein-Based Pneumococcal Vaccine in Healthy Adults Aged 18-49: A Phase Ia Randomized, Double Blind, Placebo-Controlled Clinical Study.
Vaccines (Basel). 2024 Jul 23;12(8):827. doi: 10.3390/vaccines12080827.
2
A Jack of All Trades: The Role of Pneumococcal Surface Protein A in the Pathogenesis of .
Front Cell Infect Microbiol. 2022 Feb 2;12:826264. doi: 10.3389/fcimb.2022.826264. eCollection 2022.
3
Serum levels of anti-PspA and anti-PspC IgG decrease with age and do not correlate with susceptibility to experimental human pneumococcal colonization.
PLoS One. 2021 Feb 12;16(2):e0247056. doi: 10.1371/journal.pone.0247056. eCollection 2021.
4
Virulence-Associated Characteristics of Serotype 14 and Serogroup 9 Clones Circulating in Brazil: Association of Penicillin Non-susceptibility With Transparent Colony Phenotype Variants.
Front Microbiol. 2020 Aug 26;11:2009. doi: 10.3389/fmicb.2020.02009. eCollection 2020.
5
[Regional System for Vaccines (SIREVA), laboratory surveillance and vaccine development for : bibliometric analysis, 1993-2019].
Rev Panam Salud Publica. 2020 Aug 6;44:e80. doi: 10.26633/RPSP.2020.80. eCollection 2020.
6
Pneumococcal Vaccines.
Microbiol Spectr. 2019 Nov;7(6). doi: 10.1128/microbiolspec.GPP3-0028-2018.
7
Prevalence of PspA families and pilus islets among Streptococcus pneumoniae colonizing children before and after universal use of pneumococcal conjugate vaccines in Brazil.
Braz J Microbiol. 2020 Jun;51(2):419-425. doi: 10.1007/s42770-019-00179-y. Epub 2019 Dec 4.
8
Comparison of four adjuvants revealed the strongest protection against lethal pneumococcal challenge following immunization with PsaA-PspA fusion protein and AS02 as adjuvant.
Med Microbiol Immunol. 2019 Apr;208(2):215-226. doi: 10.1007/s00430-019-00579-9. Epub 2019 Feb 1.
9
The diversity of the proline-rich domain of pneumococcal surface protein A (PspA): Potential relevance to a broad-spectrum vaccine.
Vaccine. 2018 Oct 29;36(45):6834-6843. doi: 10.1016/j.vaccine.2018.08.045. Epub 2018 Oct 5.
10
Genetic diversity of pneumococcal surface protein A in invasive pneumococcal isolates from Korean children, 1991-2016.
PLoS One. 2017 Nov 13;12(11):e0183968. doi: 10.1371/journal.pone.0183968. eCollection 2017.
本文引用的文献
1
Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae.
Infect Immun. 2000 Oct;68(10):5889-900. doi: 10.1128/IAI.68.10.5889-5900.2000.
2
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group.
Pediatr Infect Dis J. 2000 Mar;19(3):187-95. doi: 10.1097/00006454-200003000-00003.
3
Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae.
Infect Immun. 2000 Feb;68(2):796-800. doi: 10.1128/IAI.68.2.796-800.2000.
4
Effects of active immunization with a pneumococcal surface protein (PspA) and of locally applied antibodies in experimental otitis media.
ORL J Otorhinolaryngol Relat Spec. 1999 Jul-Aug;61(4):206-11. doi: 10.1159/000027672.
5
Penicillin-resistant Streptococcus pneumoniae in Colombia: presence of international epidemic clones. Colombian pneumococcal study group.
Microb Drug Resist. 1998 Fall;4(3):233-9. doi: 10.1089/mdr.1998.4.233.
6
Molecular epidemiologic characterization of penicillin-resistant Streptococcus pneumoniae invasive pediatric isolates recovered in six Latin-American countries: an overview. PAHO/Rockefeller University Workshop. Pan American Health Organization.
Microb Drug Resist. 1998 Fall;4(3):195-207. doi: 10.1089/mdr.1998.4.195.
7
A nontoxic adjuvant for mucosal immunity to pneumococcal surface protein A.
J Immunol. 1998 Oct 15;161(8):4115-21.
8
Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA).
Clin Microbiol Rev. 1998 Oct;11(4):645-57. doi: 10.1128/CMR.11.4.645.
9
Comparison of the PspA sequence from Streptococcus pneumoniae EF5668 to the previously identified PspA sequence from strain Rx1 and ability of PspA from EF5668 to elicit protection against pneumococci of different capsular types.
Infect Immun. 1998 Oct;66(10):4748-54. doi: 10.1128/IAI.66.10.4748-4754.1998.
10
Invasive Streptococcus pneumoniae infection in Latin American children: results of the Pan American Health Organization Surveillance Study.
Clin Infect Dis. 1998 Jun;26(6):1355-61. doi: 10.1086/516350.
Zotero 插件